Trial Profile
Effect of Inhibition Soluble Epoxide Hydrolase on Insulin Sensitivity in Humans
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2023
Price :
$35
*
At a glance
- Drugs GSK 2256294 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 01 Oct 2022 Status changed from active, no longer recruiting to completed.
- 17 May 2022 Status changed from recruiting to active, no longer recruiting.
- 18 Nov 2021 Planned primary completion date changed from 1 Oct 2021 to 1 Oct 2022.